EHRA 2021 - CCM® in HF - Mechanism and Clinical Evidence

974 views
April 16, 2021
This video is a lecture from EHRA 2021 Virtual Scientific Session titled CCM® in Heart Failure: Mechanisms and Clinical Evidence. Dr. Ken Ellenbogen moderates this session. Dr. Jagmeet Singh discusses the need to incorporate device based therapy for the management of heart failure in addition to guideline directed medical therapy. Dr. Jurgen Kuschyk discusses the procedure of implanting a CCM device while highlighting the safety profile and clinical evidence surrounding this therapy. The faculty panel discusses that any physician that can prescribe guideline directed medical therapy can also screen patients for CCM® therapy.

  • October 26, 2021 - U.S. Food and Drug Administration approved a modification of labeling for the Optimizer® Smart medical device, allowing the removal of “normal sinus rhythm” (NSR) from the indications for use statement as of 10/26/2021. Please note that this presentation was done prior to this FDA update.
0 Comments
Login to view comments. Click here to Login